此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Generative AI-Powered Intrapartum Clinical Decision Support Among Healthcare Providers

2026年11月5日 更新者:Delta University for Science and Technology

Generative AI-Powered Intrapartum Clinical Decision Support and Healthcare Providers' Decision-Making Speed, Diagnostic Accuracy, Satisfaction, and Clinical Experience: A Quasi-Experimental Study

Pregnancy and childbirth are uniquely important events in women's lives because they are accompanied by major physical, emotional, and psychological changes. Maternal satisfaction, emotional well-being, and perceptions of childbirth are strongly influenced by the quality of labor management. A woman's childbirth experience is shaped by multiple factors, including communication, autonomy, and active participation in the decision-making process. These factors are widely recognized as important indicators of the quality of maternity care. [1]

Recent demographic changes and global population growth have placed increasing demands on healthcare systems, particularly maternal health services. High birth rates in some regions, combined with shortages of trained healthcare professionals, have created a need for scalable, adaptable, and innovative models of care. In response to these challenges, digital health technologies have emerged as promising tools to enhance the quality of maternity care and support both healthcare providers and pregnant women. [2]

研究概览

详细说明

This single-center, non-randomized, parallel-group quasi-experimental study evaluated a generative AI-powered intrapartum clinical decision-support chatbot among healthcare providers involved in normal labor management.

The study included 427 obstetricians and nurses: 214 in the intervention group and 213 in the control group. Providers in the intervention group used the AI-based Smart Normal Labor application to support clinical assessment and decision-making during routine labor care. Providers in the control group followed conventional institutional care practices without using the application.

The evaluation combined assessments of clinical decision-making performance with provider-reported satisfaction, acceptance, clinical experience, and workflow. It also explored perceived barriers and facilitators to application use in clinical practice. The study focused on provider-level outcomes; maternal and neonatal clinical outcomes were not directly assessed.

研究类型

介入性

注册 (实际的)

427

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Dakahlia Governorate
      • Al Mansurah、Dakahlia Governorate、埃及、35712
        • Basma wageah Basma

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子
  • 成人
  • 年长者

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria

Obstetricians and nurses working in the Labor Kiosk, Obstetrics and Gynecology Department, or Outpatient Gynecology Clinics at Mansoura University Hospital.

Direct involvement in the care and supervision of women in active labor.

At least six months of clinical experience in labor management. For the intervention group: completion of at least two months of training on the generative AI-powered Smart Normal Labor intrapartum chatbot before its use with clinical cases during the intervention.

For the intervention group: use of the generative AI-powered Smart Normal Labor intrapartum chatbot during clinical labor management.

For the control group: provision of routine care without prior use of the study chatbot.

Willingness to participate and provide informed consent.

Exclusion Criteria

Healthcare providers not directly involved in labor management, including administrative staff and laboratory personnel.

Less than six months of clinical experience in labor management.

Being on leave or unavailable during the study period.

Declining participation or not providing informed consent.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:非随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Generative AI-Powered Intrapartum Chatbot Decision Support Group

Healthcare providers used the generative AI-powered Smart Normal Labor intrapartum chatbot to support clinical assessment, interpretation of labor progress, and clinical decision-making during normal labor management. The chatbot was used alongside routine institutional care practices.

Smart Normal Labor is a mobile application incorporating a generative AI-powered chatbot for healthcare providers. It provides interactive clinical decision support using information entered by providers about labor progress and clinical findings. Its intended functions include supporting interpretation of clinical information and formulation of a management plan.

其他名称:
  • Smart Normal Labor
无干预:Routine Care Group

Healthcare providers managed normal labor according to routine institutional care practices without using the generative AI-powered intrapartum chatbot.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Time to a Confirmed Intrapartum Management Decision
大体时间:During the assessed intrapartum clinical encounter, from case presentation to confirmation of the management decision ,5 months

Elapsed time, measured in minutes, from admission of the woman in labor to confirmation of a clinical management plan by the healthcare provider. Shorter times indicate faster clinical decision-making.

During the assessed intrapartum clinical encounter, from case presentation to confirmation of the management decision ,5 months

次要结果测量

结果测量
措施说明
大体时间
Diagnostic Accuracy in Intrapartum Clinical Cases
大体时间:During the assessed intrapartum clinical encounter, at completion of the diagnostic assessment ,5 months.

Percentage of assessed intrapartum clinical cases in which the healthcare provider's diagnosis agrees with the study-defined reference diagnosis, compared between the AI-supported intervention group and the conventional-care control group. Higher percentages indicate greater diagnostic accuracy.

During the assessed intrapartum clinical encounter, at completion of the diagnostic assessment ,5 months.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年5月6日

初级完成 (实际的)

2026年10月25日

研究完成 (实际的)

2026年10月29日

研究注册日期

首次提交

2026年4月4日

首先提交符合 QC 标准的

2026年7月21日

首次发布 (实际的)

2026年7月22日

研究记录更新

最后更新发布 (实际的)

2026年11月9日

上次提交的符合 QC 标准的更新

2026年11月5日

最后验证

2026年1月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅